ARCHIVES

NCI apologize For Mismanagement Of NSABP, Says Fisher Resisted Criticism

This article is from The Cancer Letter archive.

Vol. 20 No. 16 | April 22, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Information for 5-Alpha Reductase Inhibitors

June 17, 2011

CR Funds Agencies At FY08 Level Through March 6.

October 3, 2008

ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies

May 2, 2003

NCI Human Tissue Network Resources Available For Research

January 24, 1997

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986

Pennsylvania Cancer Center Gets $100 Million; Watson, Weinberg, Win National Science Medals

December 19, 1997